A Case Report with Severe Thrombocytopenia Induced by Axitinib

Axitinib is an oral, second-generation tyrosine kinase inhibitor that is selective for vascular endothelial growth factor receptors (VEGFR). This agent is approved as monotherapy or in combination with immune checkpoint inhibitors for the treatment of metastatic renal cell carcinoma. Axitinib is ass...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Case Rep Hematol
Autors principals: Koksal, Ulkuhan I., Goffin, Janeiro Valle, Lewis, Brian, Sartor, Oliver A., Belyaeva, Elizaveta, Socola, Francisco, Barata, Pedro C.
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2020
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7029294/
https://ncbi.nlm.nih.gov/pubmed/32089908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/7520783
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars